[ACRS] YoY Quarter Result on 30-Jun-2017 [#Q2]

Stock
[ACRS] Aclaris Therapeutics, Inc.
Announcement Date
08-Aug-2017
Financial Year
2017
Quarter
30-Jun-2017 [#Q2]
Profit Trend
QoQ- -18.15%
YoY- -15.28%
Quarter Report
ACRS's Result
ACRS's Financial Summary
View:
Show?
Quarter Result
30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 CAGR
Revenue 2,046 5,865 3,676 0 0 0 0 -
PBT -11,570 -49,876 -31,218 -14,838 -12,871 -2,594 -1,632 38.56%
Tax 27 18,504 1,500 0 0 0 457 -37.56%
NP -11,597 -49,876 -31,218 -14,838 -12,871 -2,594 -2,088 33.04%
Tax Rate - - - - - - - -
Total Cost 13,643 55,741 34,894 14,838 12,871 2,594 2,088 36.69%
Ratio Analysis
30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 CAGR
NP Margin -566.81 -850.40 -849.24 0.00 0.00 0.00 0.00 -
Per Share
30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 CAGR
EPS -0.28 -1.21 -1.01 -0.56 -0.62 -0.13 -1.25 -22.05%
EPS Diluted -0.28 -1.21 -1.01 -0.56 -0.62 -0.13 -1.25 -22.05%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.